Biovail Corporation And Ortho-McNeil Pharmaceutical, Inc. Partnership Receives Hart-Scott-Rodino Regulatory Clearance

TORONTO--(BUSINESS WIRE)--Dec. 2, 2005--Biovail Corporation (NYSE:BVF)(TSX:BVF) today announced that the Company and its partner, Ortho McNeil, Inc., a Johnson & Johnson company, have received Hart-Scott-Rodino regulatory clearance in the United States for their supply agreement for the marketing and distribution of a once-daily extended-release formulation and an orally disintegrating, immediate-release tablet formulation of tramadol in the United States and Puerto Rico. Both formulations have already been approved by the United States Food and Drug Administration (FDA).